Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.
about
Corticostriatal Dysfunction in Huntington's Disease: The BasicsCurrent approaches to enhance glutamate transporter function and expressionSynaptic dysfunction and septin protein family members in neurodegenerative diseasesCortical efferents lacking mutant huntingtin improve striatal neuronal activity and behavior in a conditional mouse model of Huntington's diseaseAntibiotic treatment attenuates behavioral and neurochemical changes induced by exposure of rats to group a streptococcal antigenCeftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice.Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets.Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.The glutamate aspartate transporter (GLAST) mediates L-glutamate-stimulated ascorbate-release via swelling-activated anion channels in cultured neonatal rodent astrocytes.Blood-brain barrier permeability and brain uptake mechanism of kainic acid and dihydrokainic acid.Real Time In Vivo Measurement of Ascorbate in the Brain Using Carbon Nanotube-Modified Microelectrodes
P2860
Q26738379-B9DA5216-F6A7-41C7-9E90-3EDC38D503A2Q26996723-028B4E6F-86AE-4C43-8FEF-2A418349083EQ27026829-6D8535F8-EE1C-4FC4-B141-148B7400BFF8Q35164101-4862332E-8B58-46BF-8229-21ACAD3D3B6EQ35198301-80639DA9-2269-4018-AA94-F96BE920CBADQ36248928-44532734-BCF1-43C4-8A42-0FE43CC64885Q38035863-8A84B661-011F-4654-9EC5-8E936977A92EQ38663090-13458ECF-4441-4D0D-8C2C-DC2333A6B321Q38726920-50CB2A54-C059-44AB-8189-91688048F160Q39181656-92D4C9BE-18B7-4C64-BD2A-59CF567B49FAQ39400501-A6A6406D-276D-41BF-88CA-23D658B24529Q39425339-A38F7DC3-7930-49BF-814C-D50BE3840ADFQ44938207-0244C100-199C-4475-9622-C60508E8EF7CQ48419626-0A2DD66F-2058-4D75-AE2E-12ECA83C552DQ57342935-D78F6B6F-9BE8-4F32-8E4C-C8EFE31361C5
P2860
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@ast
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@en
type
label
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@ast
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@en
prefLabel
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@ast
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@en
P2093
P2860
P1476
Up-regulation of GLT1 reverses ...... model of Huntington's disease.
@en
P2093
Emma L Klein
George V Rebec
Jenelle L Dorner
Kendra D Bunner
Scott J Barton
Thomas W Gaither
P2860
P304
P356
10.1111/J.1471-4159.2012.07691.X
P407
P577
2012-03-28T00:00:00Z